SWK Holdings Corp.
(NASDAQ : SWKH)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Miscellaneous » Miscellaneous
symbolcompany%chnglast%shortavg$volume
PRPLPurple Innovation, Inc. 5.03%30.670.0%$41.86m
CLSKCleanspark, Inc. -1.27%10.930.0%$15.31m
ZOMZomedica Corp. 6.78%0.130.0%$8.19m
LMBLimbach Holdings, Inc. 0.50%11.980.8%$2.59m
SHIPSeanergy Maritime Holdings Corp. 1.75%0.463.0%$2.54m
CCNCCode Chain New Continent Ltd. -0.61%1.620.0%$0.29m
INVOINVO BioScience, Inc. 1.58%3.220.0%$0.27m
PMEPingtan Marine Enterprise, Ltd. -4.89%1.750.9%$0.16m
PANLPangaea Logistics Solutions Ltd. -0.72%2.770.0%$0.15m
SWKHSWK Holdings Corp. -10.79%13.070.0%$0.12m

Company Profile

SWK Holdings Corp. is engaged in the business of financial and asset management in the field of pharmaceutical. The company offers capital and investments in life science companies, institutions and inventors. It engages in royalty purchases and financings, as well as commercialization of products. The firm operates through the following segments: Finance Receivables and Pharmaceutical Development. The Finance Receivables segment is a healthcare capital provider which offers customized financing solutions to a broad range of life science companies, institutions and inventors. It is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. The Pharmaceutical Development segment strategy is to utilize the Peptelligence platform to create a wholly-owned portfolio of milestone and royalty income by out-licensing the technology. The company was founded in July 1996 and is headquartered in Dallas, TX.